Edesa Biotech (EDSA) Return on Sales (2013 - 2021)
Edesa Biotech (EDSA) posted Return on Sales of 233.43% for Q2 2021, down 29620.17% sequentially from 0.79% in Q1 2021, and down 23327.0% YoY from N/an in Q2 2020.
Edesa Biotech (EDSA) Return on Sales (2013 - 2021) Analysis & Trends
Edesa Biotech has reported Return on Sales for 9 years, with the latest figure at 233.43% in Q2 2021.
- Quarterly Return on Sales fell 23327.0% year-over-year to 233.43% in Q2 2021, while the trailing twelve-month figure through Jun 2021 was 233.43% (down 23330.0% YoY) and the FY2020 annual result came in at 0.19%, down 13.0% from the prior year.
- Return on Sales eased to 233.43% in Q2 2021 per EDSA's latest filing, from 0.79% in the prior quarter.
- Over five years, Return on Sales peaked at 0.56% in Q2 2018 and troughed at 233.43% in Q2 2021.
- A 5-year average of 18.96% and a median of 0.48% in 2017 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2020 and 2021: Return on Sales surged 2572 bps in 2020, then slumped 23327 bps in 2021.
- Over 5 years, Return on Sales stood at 0.68% in 2017, then rose by 9 bps to 0.62% in 2018, then soared by 84 bps to 0.1% in 2019, then slumped by 252 bps to 0.36% in 2020, then plunged by 65140 bps to 233.43% in 2021.
- According to Business Quant data, Return on Sales over the past three periods registered 233.43%, 0.79%, and 0.36% for Q2 2021, Q1 2021, and Q4 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - | 0.00% |
| 10 | Edesa Biotech | 41.70 Mn | 41.70 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -233.43% |
| Mar 31, 2021 | -0.79% |
| Dec 31, 2020 | -0.36% |
| Sep 30, 2020 | -40.29% |
| Jun 30, 2020 | -0.16% |
| Mar 31, 2020 | -0.13% |
| Dec 31, 2019 | -0.10% |
| Jun 30, 2019 | -25.88% |
| Dec 31, 2018 | -0.62% |
| Sep 30, 2018 | -0.60% |
| Jun 30, 2018 | 0.56% |
| Mar 31, 2018 | -0.21% |
| Dec 31, 2017 | -0.68% |
| Sep 30, 2017 | 0.07% |
| Jun 30, 2017 | -0.59% |
| Mar 31, 2017 | -0.18% |
| Dec 31, 2016 | -0.10% |
| Sep 30, 2016 | -0.01% |
| Jun 30, 2016 | -0.07% |
| Mar 31, 2016 | -0.03% |